Mohamed A. is a Quality Control Analyst currently employed at Beam Therapeutics since May 2023, where responsibilities include routine testing on various assays such as cell-based potency assays, flow cytometry, and polymerase chain reaction, as well as managing mammalian cell lines maintenance. Prior experience at Seres Therapeutics from October 2022 to April 2023 involved conducting routine testing for PCR and bacterial cell culture, among others, while generating and reviewing GMP documentation. Previously, from October 2021 to July 2022, at Associates of Cape Cod, Inc., testing for endotoxins and drafting GMP protocols were key tasks. Mohamed A. holds a Bachelor of Science degree in Medical and Molecular Biology from Massachusetts College of Pharmacy and Health Sciences and is pursuing a Master of Science in Biotechnology at Northeastern University.
This person is not in any teams
This person is not in any offices